|
Unilab IPO comes in on top
|
 |
June 5, 2001: 6:41 p.m. ET
Clinical test provider sells 6.7M shares at $16 each via CSFB and Salomon
|
NEW YORK (CNNfn) - The initial public offering from Unilab Corp., a provider of lab testing services, came in at the top of its range Tuesday, raising $107.2 million.
Unilab sold 6.7 million shares at $16 each, the high end of its $14-to-$16 range, via lead underwriters Salomon Smith Barney and Credit Suisse First Boston.
Unilab, one of the largest clinical lab testing companies in California, provides services to physicians, hospitals and managed care groups to treat and monitor diseases. Tests range from simple glucose monitoring to specialized ones that measure HIV infection and hepatitis C. Tarzana, Calif.-based Unilab is profitable, with $3.2 million in income on $95.3 million in revenue for the quarter ended March 31.
Unilab plans to trade under the Nasdaq symbol "ULAB."' 
|
|
|
|
|
 |
|
